These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16364537)

  • 21. Cancer communication patterns and the influence of patient characteristics: disparities in information-giving and affective behaviors.
    Siminoff LA; Graham GC; Gordon NH
    Patient Educ Couns; 2006 Sep; 62(3):355-60. PubMed ID: 16860520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.
    Loeb S; Roehl KA; Antenor JA; Catalona WJ; Suarez BK; Nadler RB
    Urology; 2006 Feb; 67(2):316-20. PubMed ID: 16442597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychological aspects of screening in families with hereditary prostate cancer.
    Bratt O; Emanuelsson M; Grönberg H
    Scand J Urol Nephrol; 2003; 37(1):5-9. PubMed ID: 12745735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial factors associated with the adherence to a colorectal cancer screening program.
    Gili M; Roca M; Ferrer V; Obrador A; Cabeza E
    Cancer Detect Prev; 2006; 30(4):354-60. PubMed ID: 16963195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
    Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ
    BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of prostate-specific antigen velocity to follow up patients with isolated high-grade prostatic intraepithelial neoplasia on prostate biopsy.
    Loeb S; Roehl KA; Yu X; Han M; Catalona WJ
    Urology; 2007 Jan; 69(1):108-12. PubMed ID: 17270629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer screening behavior in men from seven ethnic groups: the fear factor.
    Consedine NS; Morgenstern AH; Kudadjie-Gyamfi E; Magai C; Neugut AI
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):228-37. PubMed ID: 16492909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between body mass index and prostate cancer screening in the United States.
    Scales CD; Curtis LH; Norris RD; Schulman KA; Dahm P; Moul JW
    J Urol; 2007 Feb; 177(2):493-8. PubMed ID: 17222617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do women have a role in early detection of prostate cancer? - Lessons from a qualitative study.
    Madjar I; Denham J; Rashid P
    Aust Fam Physician; 2007 May; 36(5):375-7. PubMed ID: 17492077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer knowledge among low income minority men.
    Deibert CM; Maliski S; Kwan L; Fink A; Connor SE; Litwin MS
    J Urol; 2007 May; 177(5):1851-5. PubMed ID: 17437834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer screening and disease management: how screening may have an unintended effect on survival and mortality-the camel's nose effect.
    Walsh RM; Thompson IM
    J Urol; 2007 Apr; 177(4):1303-6. PubMed ID: 17382719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.
    Beebe-Dimmer JL; Wood DP; Gruber SB; Douglas JA; Bonner JD; Mohai C; Zuhlke KA; Shepherd C; Cooney KA
    Urology; 2004 Feb; 63(2):282-7. PubMed ID: 14972472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer diagnosis: the impact on patients' mental health.
    Korfage IJ; de Koning HJ; Roobol M; Schröder FH; Essink-Bot ML
    Eur J Cancer; 2006 Jan; 42(2):165-70. PubMed ID: 16326098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knowledge of and attitudes about cancer among American Samoans.
    Mishra SI; Aoelua PL; Hubbell FA
    Cancer Detect Prev; 2000; 24(2):186-95. PubMed ID: 10917141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of web-assisted education and reminders on health belief, level of knowledge and early diagnosis behaviors regarding prostate cancer screening.
    Capık C; Gözüm S
    Eur J Oncol Nurs; 2012 Feb; 16(1):71-7. PubMed ID: 21530397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smokers: at risk for prostate cancer but unlikely to screen.
    Rolison JJ; Hanoch Y; Miron-Shatz T
    Addict Behav; 2012 Jun; 37(6):736-8. PubMed ID: 22370523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Employee response to a company-sponsored program of colorectal and prostate cancer screening.
    Myers RE; Vernon SW; Carpenter AV; Balshem AM; Lewis PG; Wolf TA; Hilbert J; DeFonso LR; Ross EA
    Cancer Detect Prev; 1997; 21(4):380-9. PubMed ID: 9232330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of complementary therapies among breast and prostate cancer patients during treatment: a multisite study.
    Hann DM; Baker F; Roberts CS; Witt C; McDonald J; Livingston M; Ruiterman J; Ampela R; Crammer C; Kaw O
    Integr Cancer Ther; 2005 Dec; 4(4):294-300. PubMed ID: 16282506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a camp setting to provide medical information to siblings of pediatric cancer patients.
    Carpenter PJ; Sahler OJ; Davis MS
    J Cancer Educ; 1990; 5(1):21-6. PubMed ID: 2400666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.